Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-zhejiang-hisun-pharmaceuticals-1648618859.pdf
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-zhejiang-hisun-pharmaceuticals-81117-483-1648619084.pdf
https://www.prnewswire.com/news-releases/zhejiang-hisun-pharmaceutical-co-ltd-free-of-covid-19-governments-suggest-favipiravir-301086032.html
https://www.prnewswire.com/news-releases/zhejiang-hisun-pharmaceutical-co-ltd-free-of-covid-19-governments-suggest-favipiravir-301084393.html
https://www.prnewswire.com/news-releases/zhejiang-hisun-pharmaceutical-co-ltd-free-of-covid-19-governments-suggest-favipiravir-301084393.html
https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-on-health-canada-inspection-list-1593060758.pdf
https://www.biospectrumasia.com/news/25/15639/zhejiang-hisun-shows-positive-effect-of-favipiravir-on-covid-19.html
https://www.prnewswire.com/news-releases/zhejiang-hisun-pharmaceutical-co-ltd-favipiravir-works---preliminary-clinical-studies-suggest-positive-effects-on-covid-19-patients-301027036.html